Sun care growth
This article was originally published in The Rose Sheet
Executive Summary
The U.S. market for sun care products grew 15% between 2001 and 2006, yet constant pricing exhibited zero growth, according to Dublin-based market research firm Research and Markets. "While there has been healthy growth in the sunless tanner segment, sales of tanning lotion and oils have not been as robust, while after-sun product has declined 20% in constant prices from 2001-06," firm notes. Data is included in a new report, which also "reveals the attitudes, needs and behavior of consumers," with analysis broken down by demographic characteristics and segment, company says. L'Oréal, Johnson & Johnson, Playtex and Schering-Plough are among firms mentioned in the report...
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.